PFS was significantly improved with trastuzumab emtansine compared with physician 's choice ( median 62 months [ 95 % CI 559-687 ] vs 33 months [ 289-414 ] ; stratified hazard ratio [ HR ] 0528 [ 0422-0661 ] ; p < 00001 ) .